Real American Capital Corp
OTC:RLAB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Real American Capital Corp
OTC:RLAB
|
US |
|
Progressive Care Inc
OTC:RXMD
|
US |
|
Fibrobiologics Inc
F:SG0
|
US |
|
Orbis Se
F:OBS
|
DE |
|
Medical Cannabis Payment Solutions
OTC:REFG
|
US |
|
Rooshine Inc
OTC:RSAU
|
US |
Shareholder Yield
Current shareholder yield for RLAB is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
RLAB Price
Real American Capital Corp
| Average Annual Return | 403.21% |
| Standard Deviation of Annual Returns | 855.89% |
| Max Drawdown | -88% |
| Market Capitalization | 20.7m USD |
| Shares Outstanding | 1 742 445 |
| Percentage of Shares Shorted |
N/A
|
RLAB Return Decomposition
Main factors of price return
Stock Splits
RLAB's latest stock split occurred on Dec 4, 2025
The company executed a 1-for-50 stock split, meaning that for every 50 shares held, investors received 1 new share.
Before the split, RLAB traded at 0.305 per share. Afterward, the share price was about 15.
The adjusted shares began trading on Dec 4, 2025. This was stock split number 5 in RLAB's history, following the previous one in Jul 13, 2011.
